PRESS RELEASE published on 08/06/2024 at 21:07, 1 year 8 months ago Evotec provides guidance update Evotec SE refines guidance for fiscal year 2024, expecting moderate revenue growth, reduced R&D expenditures, and adjusted EBITDA; aims for sustainable profitable growth amid market challenges Adjusted EBITDA Revenue Growth Evotec SE Guidance Update R&D Expenditures
PRESS RELEASE published on 08/06/2024 at 21:04, 1 year 8 months ago EQS-Adhoc: Evotec SE provides guidance update Evotec SE refines guidance for fiscal year 2024, expecting revenue and EBITDA adjustments due to slower sales conversion and margin pressures, focusing on sustainable growth EBITDA Revenue Evotec SE Sustainable Growth Guidance Update
BRIEF published on 07/10/2024 at 07:35, 1 year 9 months ago Evotec and Pfizer Collaborate to Advance Drug Discovery in France Drug Discovery Metabolic Diseases Evotec Pfizer Infectious Diseases
PRESS RELEASE published on 07/10/2024 at 07:30, 1 year 9 months ago Evotec and Pfizer collaborate to advance drug discovery in France Evotec SE collaborates with Pfizer to focus on early discovery research for metabolic and infectious diseases in France. The multi-year agreement includes research support and potential milestones Drug Discovery Evotec SE France Pfizer Metabolic And Infectious Diseases
BRIEF published on 07/08/2024 at 14:05, 1 year 9 months ago Just – Evotec Biologics Expands Tech Partnership for Biosimilars with Sandoz Partnership Biosimilars Evotec Sandoz Biologics
PRESS RELEASE published on 07/08/2024 at 14:00, 1 year 9 months ago Just – Evotec Biologics expands tech partnership for biosimilars with Sandoz Evotec SE's biologics segment, Just - Evotec Biologics, expands partnership for biosimilars with Sandoz, securing long-term commercial supply. Collaboration aims for cost-efficient development Evotec SE Biosimilars Just - Evotec Biologics Sandoz Commercial Supply
BRIEF published on 06/25/2024 at 07:35, 1 year 10 months ago Just-Evotec Biologics Selected by U.S. DOD for Manufacturing Optimization Evotec SE Biologics Manufacturing U.S. Department Of Defense Monoclonal Antibodies Medical Countermeasures
PRESS RELEASE published on 06/25/2024 at 07:30, 1 year 10 months ago Just – Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program Just \/ Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program. Evotec SE subsidiary chosen for $39m accelerated mAb development project Evotec SE Just - Evotec Biologics U.S. Department Of Defense Manufacturing Optimization Program MAb Development
BRIEF published on 06/12/2024 at 07:35, 1 year 10 months ago Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb Collaboration Neuroscience Evotec Neurodegenerative Diseases Bristol Myers Squibb
PRESS RELEASE published on 06/12/2024 at 07:30, 1 year 10 months ago Evotec announces progress in neuroscience collaboration with Bristol Myers Squibb Evotec SE makes progress in neuroscience collaboration with Bristol Myers Squibb, receiving a US$20m research payment. The partnership focuses on developing treatments for neurodegenerative diseases Evotec SE Neurodegenerative Diseases Bristol Myers Squibb Neuroscience Collaboration Research Payment
Published on 05/02/2026 at 01:30, 3 hours 26 minutes ago Uraniumx Reports Strong Financial Position Ahead of Spring Drill Program
Published on 05/02/2026 at 00:50, 4 hours 6 minutes ago CoTec Announces Annual Stock Option, Restricted Share Unit And Deferred Share Unit Grants
Published on 05/02/2026 at 00:00, 4 hours 56 minutes ago Redwood AI Announces Enhanced AI Models, Increasing Evaluated Chemical Reactions Following Preliminary Results from UBC Collaboration
Published on 05/02/2026 at 00:00, 4 hours 56 minutes ago Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies
Published on 05/01/2026 at 22:30, 6 hours 26 minutes ago Nextech3D.ai Appoints New Independent Auditor
Published on 05/01/2026 at 19:23, 9 hours 33 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/01/2026 at 17:45, 11 hours 11 minutes ago Burkhalter Group acquires Progressio Holding GmbH and anplaq ag, Tamins (GR)
Published on 05/01/2026 at 17:21, 11 hours 34 minutes ago Fuller, Smith & Turner PLC: Total Voting Rights and Treasury Shares
Published on 04/30/2026 at 20:00, 1 day 8 hours ago AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 1 day 9 hours ago AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 1 day 9 hours ago Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 1 day 10 hours ago Minutes of the Combined General Meeting held on April 30, 2026
